Le Lézard
Classified in: Health
Subject: PER

Common Sensing Announces Appointment of John R. Dwyer to Board of Directors


CAMBRIDGE, Mass., Aug. 22, 2019 /PRNewswire/ -- Common Sensing, creators of Gocap: a dose and adherence monitoring device for injectable medicine, today announced that it has appointed John R. Dwyer, President of the Global Alzheimer's Platform Foundation and Co-Founder of Telcare, Inc., to its Board of Directors.

Common Sensing, Inc. (PRNewsfoto/Common Sensing)

Mr. Dwyer is a successful healthcare entrepreneur who has held C-level positions in six emerging growth companies in the healthcare industry. He began his career as an attorney for the Washington DC based law firm of Arent, Fox LLP, where he focused on transactions in regulated industries.

He has led the acquisition of Active Health Management by Aetna in 2005, the purchase of CodeRyte by 3M in 2012, and the acquisition of Telcare, Inc. by BioTelemetry, Inc. in 2016.

"We are honored to have John Dwyer join our Board of Directors. John's multi-disciplinary experience in numerous leadership roles as well as his expertise in financial and regulatory aspects of emerging health technology companies is outstanding. John will be a tremendous resource as we navigate the regulatory process and partner with payors as we execute our global commercial strategy," said Common Sensing Chief Executive Officer Kevin Schmid.

"I have a deep personal commitment to improving the lives of patients and caregivers through medical devices and healthcare services and am excited to join the Common Sensing Board of Directors to guide and support their team and their mission," stated Mr. Dwyer.

Mr. Dwyer currently serves on the Boards of Directors of a number of private and not-for-profit organizations. Mr. Dwyer is a graduate of Marquette University and the Cornell Law School.

Media Contact
Kelly Pavao
[email protected]

SOURCE Common Sensing


These press releases may also interest you

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...



News published on and distributed by: